Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYPAZ: An Open-label Investigation Into Hypertension Induced by Pazopanib Therapy

NCT01392352 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT01392352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01392352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYPAZ: An Open-label Investigation Into Hypertension Induced by Pazopanib Therapy
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2011
Completion date
September 30, 2015
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical cancer, gastrointestinal cancer, glioblastoma, melanoma, non-small cell lung cancer, ovarian cancer, pancreatic cancer, renal cell carcinoma, small cell lung cancer, soft tissue sarcoma